Edition:
United Kingdom

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

21.95USD
21 May 2018
Change (% chg)

$0.35 (+1.62%)
Prev Close
$21.60
Open
$21.60
Day's High
$22.40
Day's Low
$21.50
Volume
146,823
Avg. Vol
74,235
52-wk High
$30.45
52-wk Low
$16.85

Chart for

About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $1,235.81
Shares Outstanding(Mil.): 55.79
Dividend: --
Yield (%): --

Financials

  AXDX.OQ Industry Sector
P/E (TTM): -- 34.72 32.53
EPS (TTM): -1.28 -- --
ROI: -51.41 8.07 12.63
ROE: -80.45 11.48 14.50

BRIEF-Accelerate Diagnostics Q1 Loss Per Share $0.37

* Q1 EARNINGS PER SHARE VIEW $-0.32 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

09 May 2018

BRIEF-Accelerate Diagnostics announces pricing of $150 mln notes offering

* ACCELERATE DIAGNOSTICS, INC. ANNOUNCES PRICING OF $150 MILLION CONVERTIBLE NOTES OFFERING

23 Mar 2018

BRIEF-Accelerate Diagnostics Announces $150 Mln Convertible Notes Offering

* ACCELERATE DIAGNOSTICS INC. ANNOUNCES $150 MILLION CONVERTIBLE NOTES OFFERING

22 Mar 2018

BRIEF-Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share

* ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017

15 Feb 2018

Earnings vs. Estimates